Navigation Links
Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting
Date:5/19/2008

Progenitor Cell Mobilization Observed in Subjects with Critical Limb

Ischemia Treated with ZFP Therapeutic

MIAMI, May 19 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of data from a Phase 1 clinical trial of a zinc finger DNA-binding protein activator of vascular endothelial growth factor (ZFP-VEGF) in subjects with critical limb ischemia (CLI). The data demonstrate that administration of ZFP-VEGF resulted in a statistically significant increase in circulating progenitor or stem cells in the peripheral blood. In addition, within a subgroup in which bone marrow cells were examined before and after treatment, the data suggests that subjects who showed the most marked clinical improvements, as judged by limb salvage, ulcer healing, reduction in pain and increased oxygen concentrations in the tissues, also showed the greatest increase in bone marrow stem cells. The trial was conducted by principal investigator Brian Annex, M.D., Director, Vascular Medicine and his colleagues at Duke University Medical Center.

"The data obtained in this clinical trial are very interesting and may have important implications for assessing biological activity and efficacy of this therapeutic strategy," commented the presenter, Robert Mitchell, M.D., of the department of medicine at Duke University Medical Center. "Several of the subjects in this trial were already scheduled for amputation but chose to enroll in this important trial. Within a subgroup analysis, the data demonstrate that the best clinical responders had the largest fold increase in bone marrow stem cells twelve days after dosing. Increased mobilization of stem cells, which may be involved in tissue regeneratio
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Sangamo BioSciences Nominates Thomas G. Wiggans to Its Board of Directors
2. Sangamo BioSciences Announces First Quarter Conference Call and Webcast
3. Sangamo BioSciences Announces License Agreement For the Use of ZFP Technology For Generation of Transgenic Animals
4. Sangamo BioSciences to Present at the Cowen and Company 28th Annual Health Care Conference
5. Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production
6. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
7. Sangamo BioSciences to Present at the BIO CEO & Investor Conference
8. Sangamo BioSciences Announces Fourth Quarter and Year-End 2007 Conference Call and Webcast
9. Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing
10. Sangamo BioSciences to Present at the BMO Capital Markets Health Care Conference
11. Sangamo BioSciences to Present at the Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... and PHILADELPHIA , Nov. 26, 2014 ... and unforgiving environments. Human exploration of space requires astronauts ... ensure mission safety and success, and prevent potential errors ... mission success, little is known about how cognition is ... are primarily affected. Now, Penn Medicine researchers ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 On January, ... the Baltimore and Washington D.C. science community to the ... The event, sponsored by the Protein Society, will take ... University Center, Room 312. Through discussion, presentations and ... structural importance of proteins, their role in the industry ...
(Date:11/26/2014)... NC (PRWEB) November 26, 2014 PMG ... Advisory Board. PMG Research is a network of sites that ... access to over 2 million patient lives through its partnerships ... is comprised of 11 hub site locations in the Southeastern ... The first term of the board will be ...
(Date:11/26/2014)... SonaCare Medical, a leading manufacturer of ... participated in the American Urology Association’s (AUA) surgical ... opinion leaders in urology presented on the latest ... masses while attendees had the opportunity to evaluate ... labs. Attendees at the Los Angeles, CA lab, ...
Breaking Biology Technology:Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 2Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 3Penn Medicine Team Develops Cognitive Test Battery to Assess the Impact of Long Duration Spaceflights on Astronauts' Brain Function 4PMG Research Names Medical Advisory Board 2PMG Research Names Medical Advisory Board 3SonaCare Medical Supports American Urology Association’s Small Renal Mass 360° Summit 2SonaCare Medical Supports American Urology Association’s Small Renal Mass 360° Summit 3
... 27 Craneware , Inc. (AIM: ... U.S. healthcare, today announced a presentation at the Healthcare ... for November 5-7 in Chicago, IL. The session will ... 30 years experience - Director of Revenue Integrity, Wendi ...
... Oct. 27 Precision Antibody(TM) has been selected as ... Cancer Institute (NCI),s Clinical Proteomic Technologies for Cancer (CPTC), ... the quality of monoclonal antibody reagents available for clinical ... of a third solicitation for contract proposals from custom ...
... 27 Syngenta Ventures announced today that it has ... biotechnology company focused on the use of metabolomics in ... by Syngenta Ventures, Syngenta,s newly-established corporate venture capital subsidiary. ... in-house R&D work and enables us to be even ...
Cached Biology Technology:Hospitals Improve Financial Performance by Identifying Exceptions to Best Practices 2Hospitals Improve Financial Performance by Identifying Exceptions to Best Practices 3Precision Antibody Wins Contract to Develop 'Gold Standard' Antibodies as Part of National Cancer Institute's Clinical Proteomics Technologies for Cancer (CPTC) Initiative 2Precision Antibody Wins Contract to Develop 'Gold Standard' Antibodies as Part of National Cancer Institute's Clinical Proteomics Technologies for Cancer (CPTC) Initiative 3Syngenta Ventures Invests in U.S. Biotech Company Metabolon 2Syngenta Ventures Invests in U.S. Biotech Company Metabolon 3
(Date:11/18/2014)... BOSTON , Nov. 17, 2014   ... HealthCare and EMC collaborate to develop The Partners ... , The Partners Data Lake will allow ... to improve diagnostics, treatment and the lives of ... support research and clinical activities across the Partners ...
(Date:11/18/2014)... YORK , Nov. 18, 2014   ... identity authentication solutions, and MorphoTrust USA ... and services, today announced a strategic partnership to ... enterprise, motor vehicle administration (MVA), airport screening and ... in identity-related solutions, MorphoTrust serves consumers through a ...
(Date:11/12/2014)... Fla. , Nov. 12, 2014 Crossmatch™, ... today that its U.are.U ® fingerprint readers have ... chain in Central Mexico . The ... 2014 to eliminate payroll issues caused by employees clocking ... installing the U.are.U fingerprint readers, Montparnasse relied on paper ...
Breaking Biology News(10 mins):Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2
... is a leading cause of mortality worldwide, accounting for more ... is expected to exceed 12 million. The ESMO Congress provides ... on the treatment of cancer Congress Program Highlights ... trials, potentially practice changing, Promising new drugs to treat ovarian, ...
... the microscope, the bacteria start dividing normally, two cells become ... cells begin "popping," like circus balloons being struck by darts. ... captured it on video, turns out to be an example ... scientists creating living, synthetic circuits out of bacteria. Even when ...
... CHICAGO The American Dietetic Association has published an ... in schools that calls on schools and communities to ... all children and to promote educational environments that help ... lives. ADA,s updated position paper, published in the ...
Cached Biology News:35th ESMO Congress media alert 235th ESMO Congress media alert 3Popping cells surprise living circuits creators 2Popping cells surprise living circuits creators 3Schools, communities share responsibility for child nutrition 2Schools, communities share responsibility for child nutrition 3
... to be able to handle larger sample volumes, ... well as interface with telemetry systems. The ... with dogs, pigs, and primates. The system ... and the computer can be located outside the ...
... laboratories working in a regulated environment, ... pipette calibration software that automates gravimetric ... a framework that meets todays regulatory ... a secure solution that includes a ...
... in plasma from juvenile or male fish is ... chemicals (EDCs) with estrogenic effects in fish. Quantification ... for the estrogenic effects of EDCs in fish. ... double-antibody immunometric (sandwich) EIA for analyzing Vtg in ...
... target for which no antibody exists? Having difficulty ... for a variety of pharmaceutical, biotech and academic ... our technology and expertise in antibody generation to ... patented RabMAb development technology , High affinity and ...
Biology Products: